Cargando…

New Therapeutic Strategies for Lung Cancer

Detalles Bibliográficos
Autores principales: Icard, Philippe, Damotte, Diane, Alifano, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072685/
https://www.ncbi.nlm.nih.gov/pubmed/33923765
http://dx.doi.org/10.3390/cancers13081937
_version_ 1783683964047720448
author Icard, Philippe
Damotte, Diane
Alifano, Marco
author_facet Icard, Philippe
Damotte, Diane
Alifano, Marco
author_sort Icard, Philippe
collection PubMed
description
format Online
Article
Text
id pubmed-8072685
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80726852021-04-27 New Therapeutic Strategies for Lung Cancer Icard, Philippe Damotte, Diane Alifano, Marco Cancers (Basel) Editorial MDPI 2021-04-16 /pmc/articles/PMC8072685/ /pubmed/33923765 http://dx.doi.org/10.3390/cancers13081937 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Editorial
Icard, Philippe
Damotte, Diane
Alifano, Marco
New Therapeutic Strategies for Lung Cancer
title New Therapeutic Strategies for Lung Cancer
title_full New Therapeutic Strategies for Lung Cancer
title_fullStr New Therapeutic Strategies for Lung Cancer
title_full_unstemmed New Therapeutic Strategies for Lung Cancer
title_short New Therapeutic Strategies for Lung Cancer
title_sort new therapeutic strategies for lung cancer
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072685/
https://www.ncbi.nlm.nih.gov/pubmed/33923765
http://dx.doi.org/10.3390/cancers13081937
work_keys_str_mv AT icardphilippe newtherapeuticstrategiesforlungcancer
AT damottediane newtherapeuticstrategiesforlungcancer
AT alifanomarco newtherapeuticstrategiesforlungcancer